Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label and Placebo-Controlled Assessment of Sublingual Apomorphine (Kynmobi) as Adjunct Therapy for Patients With Refractory Restless Legs Syndrome

NCT05529095 is registered in ClinicalTrials.gov with William Ondo, MD as lead sponsor.

NCT NCT05529095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label and Placebo-Controlled Assessment of Sublingual Apomorphine (Kynmobi) as Adjunct Therapy for Patients With Refractory Restless Legs Syndrome
Lead sponsor
William Ondo, MD
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2022
Completion date
March 1, 2023
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome